Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patient-Reported Adverse Events and Early Treatment Discontinuation Among Patients With Multiple Myeloma.
Peipert JD, Zhao F, Lee JW, Shen SE, Ip E, O'Connell N, Carlos RC, Graham N, Smith ML, Gareen IF, Raper PJ, Weiss M, Kumar SK, Rajkumar SV, Cella D, Gray R, Wagner LI. Peipert JD, et al. Among authors: kumar sk. JAMA Netw Open. 2024 Mar 4;7(3):e243854. doi: 10.1001/jamanetworkopen.2024.3854. JAMA Netw Open. 2024. PMID: 38536173 Free PMC article. Clinical Trial.
Clinical course of patients with relapsed multiple myeloma.
Kumar SK, Therneau TM, Gertz MA, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Witzig TE, Lust JA, Larson DR, Kyle RA, Greipp PR. Kumar SK, et al. Mayo Clin Proc. 2004 Jul;79(7):867-74. doi: 10.4065/79.7.867. Mayo Clin Proc. 2004. PMID: 15244382
Response to rituximab in patients with type II cryoglobulinemia.
Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Inwards DJ, Yasenchak CA, Kumar SK, Gertz MA. Bryce AH, et al. Among authors: kumar sk. Clin Lymphoma Myeloma. 2006 Sep;7(2):140-4. doi: 10.3816/CLM.2006.n.052. Clin Lymphoma Myeloma. 2006. PMID: 17026826
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
Dispenzieri A, Kyle RA, Katzmann JA, Therneau TM, Larson D, Benson J, Clark RJ, Melton LJ 3rd, Gertz MA, Kumar SK, Fonseca R, Jelinek DF, Rajkumar SV. Dispenzieri A, et al. Among authors: kumar sk. Blood. 2008 Jan 15;111(2):785-9. doi: 10.1182/blood-2007-08-108357. Epub 2007 Oct 17. Blood. 2008. PMID: 17942755 Free PMC article.
Improved survival in multiple myeloma and the impact of novel therapies.
Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA. Kumar SK, et al. Blood. 2008 Mar 1;111(5):2516-20. doi: 10.1182/blood-2007-10-116129. Epub 2007 Nov 1. Blood. 2008. PMID: 17975015 Free PMC article.
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.
Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV. Vachon CM, et al. Among authors: kumar sk. Blood. 2009 Jul 23;114(4):785-90. doi: 10.1182/blood-2008-12-192575. Epub 2009 Jan 29. Blood. 2009. PMID: 19179466 Free PMC article.
799 results